Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhucheng Xingmao Corn Developing is a leading global enterprise specializing in the deep processing of corn to produce a wide range of industrial, food, and pharmaceutical ingredients. The company is recognized as one of the world's largest producers of inositol and corn starch, maintaining a significant market share in fermentation-derived products such as lysine and threonine. Its pharmaceutical-grade portfolio includes dextrose monohydrate and specialized starches that serve as critical excipients and raw materials for the global healthcare industry. Headquartered in Shandong, China, the company operates multiple large-scale production facilities and exports its products to over 60 countries. Xingmao plays a vital role in the life sciences supply chain by providing high-purity nutritional supplements and chemical precursors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhucheng Xingmao Corn Developing.